Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase. - Wikidata - awgldk - TriplyDB

Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.

Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.

http://www.wikidata.org/entity/Q34674316

about

Current medical treatment of estrogen receptor-positive breast cancer Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo Combination treatment of tamoxifen with risperidone in breast cancer Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.Induction of the Estrogenic Marker Calbindn-D₉k by Octamethylcyclotetrasiloxane New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells.Steroid hormone receptors as prognostic markers in breast cancer.Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer Metastatic breast cancer: Endocrine therapy landscape reshaped.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer

P2860

Q26795751-826B9A73-DBD5-49EA-B439-3206E72C6747 Q27302901-F323010E-2EBC-4A0C-A5E3-780E3225F966 Q28539274-B1B92F98-EDA9-4650-A989-29FA5131B894 Q34006827-4C5A0C0A-9464-41A8-AFD4-A3AC1E6A5A8C Q34012393-9E7DA168-E432-4491-91DC-9855AD8F85B9 Q34022694-DE06200B-90EF-4987-BABD-958303D93298 Q34667770-7FD7D81A-F12C-48EC-9C57-E9EBB289F92D Q35000235-7E35091E-30A0-418D-852A-A9DADA990098 Q35145443-5883E461-BE40-4387-A4DC-151C7528C328 Q36245954-3BE8F96A-DEE3-4534-A593-4CFE9CF1DEA8 Q36283422-29D2244D-DDD0-4EB4-8DF1-679321345D62 Q36324193-E086DF3A-D4C3-43E8-B178-A0F0E77FF452 Q37300127-3ED2551D-0E53-47E9-B5BE-21B8F16258CD Q37705673-B46D087B-D74C-4B33-A265-2A9DA162FE84 Q38598704-02D7DEB4-6436-46DA-9ADD-7BF43A239ABF Q38989942-9FDD8BFC-A92A-41F0-AB65-777372D3D8C3 Q39185424-5775FCA3-7659-4582-B818-DB250654CE91 Q41163628-7D7449C3-28DB-4BBF-BA48-AE9A5C60F82D Q45072397-D82C81AA-4757-487C-8286-1693A74F5AD4 Q47135344-A57CCEC5-5D66-4304-A3F1-CC33AC80A952 Q48213165-63E026A5-A1ED-4339-92BD-03D56D0700A6 Q57107973-077B9D40-BD2E-4226-BE1B-872C281AE953 Q58700431-070FE278-6545-4F7A-9B0F-43A3346618EB

P2860

Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.

http://www.wikidata.org/entity/Q34674316

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@ast

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@en

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@nl

type

label

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@ast

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@en

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@nl

prefLabel

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@ast

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@en

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@nl

P1433

Q34674316-0E5C3CD7-A8B1-444B-84CA-FEA494449420

P1476

Q34674316-28EE28E2-1191-493E-ADB3-27732AD9BDB0

P2093

Q34674316-117169F1-F1EC-4F18-BD72-CCCC1166DF64

Q34674316-218BCE19-4325-4307-8C81-CD7F74203931

Q34674316-2DF89582-0048-431D-AF3D-6CC90581E8DB

Q34674316-D99B8C46-23E6-42FA-8E5C-3A1AD7C42FF5

Q34674316-E2D600EB-B438-4615-850C-E88C0A6593DC

Q34674316-E9A9DA08-29F9-4827-88DC-C8A20CE1608C

P2860

Q34674316-00E970A6-CD20-42BE-BB73-2B364D31618E

Q34674316-00ED09E9-EF61-49D1-9265-96ECB0393491

Q34674316-017B1BC7-A15A-450F-8D13-65ABA9736CB4

Q34674316-01CA9A43-3827-4657-BD58-86790C645FA1

Q34674316-062E400E-70DD-4141-87B1-F4174B514DE5

Q34674316-098F771E-4949-4291-A07E-097565F35938

Q34674316-09B61B95-289D-432E-9987-EA444C9703F3

Q34674316-0B97B164-0F45-4EA3-88D4-96CAF6320AA0

Q34674316-0FCCA9AC-E58D-4045-B707-9F029179FF36

Q34674316-11D4F29B-D264-45A8-8257-B7A6DD398FB5

P304

Q34674316-AD8FD4A5-057E-4825-90AD-621557EA9FE3

P31

Q34674316-06C79618-B997-4E7B-A233-06ACBDFBD27A

P356

Q34674316-3B24BB26-AEE0-4258-B1DE-71B3F0C47B3A

P407

Q34674316-5EBF9C20-9193-4C73-9009-30B17A20E534

P433

Q34674316-00512C68-0E1F-4A23-8D85-039D4F841980

P478

Q34674316-CBFCACB3-0E21-4DD0-AC24-FE0D912D902B

P577

Q34674316-70D24CF3-4934-463F-8FD9-6CD4C4A1573C

P5875

Q34674316-5DB5C8B4-C253-423F-8567-D0AF1C073110

P698

Q34674316-358B5354-BE4F-4962-B5C1-FC2C9618122E

P932

Q34674316-74F10A9E-145E-4171-924E-CF910F9F7FBC

P356

JOURNAL.PONE.0060889

P1433

P1476

Fulvestrant-induced cell death ...... the CSK c-Src tyrosine kinase.

@en

P2093

Danielle Rivizzigno

http://www.w3.org/2001/XMLSchema#string

Kathryn R Coser

http://www.w3.org/2001/XMLSchema#string

Keiko Shioda

http://www.w3.org/2001/XMLSchema#string

Kristen R McSweeney

http://www.w3.org/2001/XMLSchema#string

Toshi Shioda

http://www.w3.org/2001/XMLSchema#string

Wei-Lan Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway

Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein

Functional regulation of oestrogen receptor pathway by the dynein light chain 1.

Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer

The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications

Ligand-induced estrogen receptor alpha degradation by the proteasome: new actors?

Autophagy and endocrine resistance in breast cancer

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Molecular determinants for the tissue specificity of SERMs

P304

e60889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0060889

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236207712

http://www.w3.org/2001/XMLSchema#string

P698

23593342

http://www.w3.org/2001/XMLSchema#string

P932

3617152

http://www.w3.org/2001/XMLSchema#string